(IBDW) iShares Trust - iShares - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E4860 • Target Maturity
IBDW: Bonds, Fixed Income Securities, Target Maturity Investments
The iShares iBonds Dec 2031 Term Corporate ETF (IBDW) is designed to track the performance of investment-grade corporate bonds maturing between January 1, 2031, and December 15, 2031. The fund adheres to a strict investment policy, allocating at least 80% of its assets to the component bonds of its underlying index and at least 90% to fixed-income securities consistent with the indexs composition. As a non-diversified fund, it may concentrate its holdings in a smaller number of issuers, which can lead to higher volatility compared to diversified funds.
From a technical standpoint, IBDW has shown stability in recent trading sessions. The funds last price of $20.65 is slightly above its 20-day SMA of $20.56 and in line with its 50-day SMA of $20.57. The 200-day SMA of $20.33 indicates that the fund has maintained a consistent upward trajectory over the longer term. With an Average True Range (ATR) of 0.16, the fund exhibits low volatility, making it suitable for risk-averse investors seeking predictable returns.
Fundamentally, IBDW manages a substantial asset base of $1.444 billion, reflecting investor confidence in its targeted maturity strategy. Given its focus on high-quality corporate bonds and a defined maturity range, the fund is well-positioned to provide returns tied to its underlying securities as they approach maturity. Over the next three months, IBDW is expected to maintain its stable performance, supported by its low volatility and alignment with the current interest rate environment. Investors seeking exposure to investment-grade corporate debt with a specific maturity profile may find IBDW a compelling addition to their portfolios.
Additional Sources for IBDW ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBDW ETF Overview
Market Cap in USD | 1,461m |
Category | Target Maturity |
TER | 0.10% |
IPO / Inception | 2021-06-22 |
IBDW ETF Ratings
Growth Rating | 9.58 |
Fundamental | - |
Dividend Rating | 76.7 |
Rel. Strength | -3.01 |
Analysts | - |
Fair Price Momentum | 20.44 USD |
Fair Price DCF | - |
IBDW Dividends
Dividend Yield 12m | 4.60% |
Yield on Cost 5y | 4.39% |
Annual Growth 5y | 38.84% |
Payout Consistency | 100.0% |
IBDW Growth Ratios
Growth Correlation 3m | 52.8% |
Growth Correlation 12m | 69.3% |
Growth Correlation 5y | -3.2% |
CAGR 5y | -0.93% |
CAGR/Max DD 5y | -0.04 |
Sharpe Ratio 12m | 1.48 |
Alpha | 3.10 |
Beta | 0.003 |
Volatility | 6.64% |
Current Volume | 145k |
Average Volume 20d | 222.5k |
As of May 09, 2025, the stock is trading at USD 20.57 with a total of 145,030 shares traded.
Over the past week, the price has changed by -0.39%, over one month by +1.60%, over three months by +1.83% and over the past year by +7.32%.
Neither. Based on ValueRay Analyses, iShares Trust - iShares is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 9.58 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBDW as of May 2025 is 20.44. This means that IBDW is currently overvalued and has a potential downside of -0.63%.
iShares Trust - iShares has no consensus analysts rating.
According to ValueRays Forecast Model, IBDW iShares Trust - iShares will be worth about 22.1 in May 2026. The stock is currently trading at 20.57. This means that the stock has a potential upside of +7.34%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 22.1 | 7.3% |